Single dose administration of factor VIIa
US10350276B2 · kind B2 · utility
0Cited by
10References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 10, 2018 |
| Grant date | Jul 16, 2019 |
| Priority date | — |
| Expiry date | Dec 10, 2038 |
Classification
- Technology area (CPC —)General
Abstract
The present invention provides methods for preventing and/or treating bleeding episodes by administering a single dose of a Factor VIIa equivalent. Preferably, the single dose comprises between about 150 and about 500 ug/kg Factor VIIa equivalent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.